Market Tracker

01/19 4:39pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.29
Delayed Data
As of Jan 19
 -0.0118 / -3.91%
Today’s Change
0.28
Today|||52-Week Range
1.12
-5.97%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.30
Today’s open0.30
Day’s range0.29 - 0.30
Volume1,908,122
Average volume (3 months)1,631,903
Market cap$77.6M
Dividend yield--
Data as of 3:59pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book1.43

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...+0.82+19.76%
LIFEaTyr Pharma Inc-0.25-7.69%
ALIMAlimera Sciences Inc-0.04-3.31%
IPCIIntellipharmaceutics...+0.07+2.74%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateMarch 10, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

Chart unavailable